Mulai
TopgOptions

NVAX Novavax Analyst Ratings

Pembelian
Novavax, Inc. (NASDAQ:NVAX)  
TopgOptions  
NASDAQ:NVAX   Novavax, Inc.
Trend Analysis Technical Indicators Fundamental Analysis NVAX nvaxlong novavax Coronavirus (COVID-19) vaccine covidvaccine coronavirusstocks covid19stock
7
0
trendanalysis indicator fundamental nvax nvaxlong novavax coronavirus vaccine covidvaccine coronavirusstocks covid19stock
On 6/15/2021 Cantor Fitzgerald brokerage Boosted the Price Target from Reduce to Overweight $217.00 to $272.00
On 5/18/2021 JPMorgan Chase & Co. brokerage Reiterated Rating from Overweight to Neutral $285.00 to $161.00
On 5/12/2021 B. Riley brokerage Lowered the Price Target from $365.00 to $286.00
On 5/12/2021 HC Wainwright brokerage Lowered the Price Target from $317.00 to $294.00

My personal price target is $240.

Looking forward to read your opinion.
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880

Ide yang Berhubungan

TopgOptions
NVAX Novavax Vaccine approved! Buy Opportunity!
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.